Cited by 16ECG Monitoring and AnalysisArtificial Intelligence in HealthcareHeart Failure Treatment and Management

Predicting Heart Failure From 12-Lead ECGs Using AI

Open access
Desai, Akshay S., Pandey, Ambarish, Suratekar, Rohit, Ahmad, Faraz S., Alger, Heather M., Anto, Ausath G., Nujum G, Suhana, Lopez-Jimenez, Francisco +10 more·2026·JACC

Abstract

BACKGROUND: Artificial intelligence applied to electrocardiograms (ECG-AI) offers a scalable approach to identify individuals at risk for heart failure (HF) and guide preventive interventions. OBJECTIVES: The purpose of this study was to assess whether ECG-AI designed to detect systolic and diastolic dysfunction enhances the prediction of incident HF over clinical risk estimation using the PREVENT-HF (Predicting Risk of Cardiovascular Disease EVENTs-Heart Failure) equation. METHODS: Baseline clinical and electrocardiogram data were pooled from the Framingham Heart Study, Multi-Ethnic Study of Atherosclerosis, and Cardiovascular Health Study. Participants with data sufficient for both ECG-AI and PREVENT-HF assessment were included. Analyses were performed on the National Heart, Lung, and Blood Institute BioDataCatalyst from July to September 2025. Risk of incident HF was estimated using previously validated ECG-AI algorithms that detect systolic (ECG-AI LEF) and diastolic (ECG-AI DD) dysfunction. Discrimination and reclassification were evaluated using Harrell's C-statistic and net reclassification improvement. RESULTS: Of 14,126 participants, positive screening rates were 2.9% for ECG-AI LEF, 11.1% for ECG-AI DD, 11.9% for the composite ECG-AI model, 25.1% for PREVENT-HF score ≥10%, and 5.8% for PREVENT-HF score ≥20%. Incident HF or death occurred in 7.7% and 15.1% of participants, respectively. Participants with positive composite ECG-AI screens at baseline had 10- to 20-fold higher risk of developing HF compared with those with negative screens. At 1, 3, 5, and 10 years, the addition of ECG-AI to PREVENT-HF yielded 1-directional net reclassification improvements ranging from 0.086 to 0.125 at a PREVENT-HF threshold of 10%, and 0.327 to 0.403 at a threshold of 20%. CONCLUSIONS: The addition of ECG-AI to PREVENT-HF improved discrimination of near-term HF risk. ECG-AI may enable population-level HF risk stratification and facilitate targeted prevention strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2025.10.065

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At present, AI-ECG is better interpreted as a tool for risk enrichment and follow-up prioritization in selected screening settings than as a stand-alone mandate for structured surveillance or immediate pathway escalation.

    “At present, AI-ECG is better interpreted as a tool for risk enrichment and follow-up prioritization in selected screening settings than as a stand-alone mandate for structured surveillance or immediate pathway escalation.12,19,44,45”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. Joynt Maddox KE, Elkind MSV, Aparicio HJ, et al. Forecasting the burden of cardiovascular disease and stroke in the United States through 2050- prevalence of risk factors and disease: a presi- dential advisory from the American Heart Associ- ation. Circulation. 2024;150(4):e65-e88. https:// doi.org/10.1161/CIR.0000000000001256 · DOI
  2. Fonarow GC, Ahmad FS, Ahmad T, et al. HF STATS 2025: heart failure epidemiology and outcomes statistics. An updated 2025 report from the Heart Failure Society of America. J Card Fail. 2025;0(0):1-60. https://doi.org/10.1016/J.CARD- FAIL.2025.07.007 · DOI
  3. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263- e421. https://doi.org/10.1016/J.JACC.2021.12.012 · DOI · Paper page
  4. Khan SS, Breathett K, Braun LT, et al. Risk- based primary prevention of heart failure: a sci- entific statement from the American Heart Asso- ciation. Circulation. 2025;151(20):e1006-e1026.
  5. Attia ZI, Kapa S, Lopez-Jimenez F, et al. Screening for cardiac contractile dysfunction us- ing an artificial intelligence-enabled electrocar- diogram. Nat Med. 2019;25(1):70-74. https://doi. org/10.1038/S41591-018-0240-2 · DOI · Paper page
  6. Dhandapani S, Somasundaram H, Angamuthu T. Hybrid deep learning framework for heart disease prediction using ECG signal images. Sci Rep. 2025;15(1):1-17. https://doi.org/ 10.1038/S41598-025-10062-6 · DOI
  7. Adedinsewo DA, Siddiqui H, Johnson PW, et al. Digitizing paper based ECG files to foster deep learning based analysis of existing clinical data- sets: an exploratory analysis. Intell Based Med. 2022;6:100070. https://doi.org/10.1016/J. IBMED.2022.100070 · DOI
  8. Dawber TR, Meadors GF, Moore FE. Epidemi- ological approaches to heart disease: the Fra- mingham Study. Am J Public Health Nations Health. 1951;41(3):279-281. https://doi.org/10. 2105/AJPH.41.3.279 · DOI · Paper page
  9. Fried LP, Borhani NO, Enright P, et al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1(3):263-276. https://doi. org/10.1016/1047-2797(91)90005-W 14. Bild DE, Bluemke DA, Burke GL, et al. Multi- Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871-881. https://doi.org/10.1093/AJE/KWF113 · DOI · Paper page
  10. Heinzel FR, Shah SJ. The future of heart failure with preserved ejection fraction: deep phenotyp- ing for targeted therapeutics. Herz. 2022;47(4): 308-323. https://doi.org/10.1007/S00059-022- 05124-8/FIGURES/6 · DOI
  11. Ahalt S, Avillach P, Boyles R, et al. Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research. J Am Med Inform Assoc. 2023;30(7):1293-1300. https://doi.org/10. 1093/JAMIA/OCAD048 · DOI
  12. Sussman JB, Wilson LM, Burke JF, Ziaeian B, Anderson TS. Clinical characteristics and current management of US adults at elevated risk for heart failure using the PREVENT equations: a cross-sectional analysis. Ann Intern Med. 2024;178(1):144. https://doi.org/10.7326/ ANNALS-24-01321 · DOI
  13. Pencina MJ, D'Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new bio- markers. Stat Med. 2011;30(1):11-21. https://doi. org/10.1002/SIM.4085 · DOI
  14. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27 (2):157-172. https://doi.org/10.1002/SIM.2929 · DOI · Paper page
  15. Yao X, Rushlow DR, Inselman JW, et al. Arti- ficial intelligence-enabled electrocardiograms for identification of patients with low ejection frac- tion: a pragmatic, randomized clinical trial. Nat Med. 2021;27(5):815-819. https://doi.org/10. 1038/S41591-021-01335-4;SUBJMETA · DOI
  16. Siontis KC, Noseworthy PA, Attia ZI, Friedman PA. Artificial intelligence-enhanced elec- trocardiography in cardiovascular disease manage- ment. Nat Rev Cardiol. 2021;18(7):465-478. https://doi.org/10.1038/S41569-020-00503-2 · DOI · Paper page
  17. Khera R, Oikonomou EK, Nadkarni GN, et al. Transforming cardiovascular care with artificial intelligence: from discovery to practice: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024;84(1):97-114. https://doi.org/10.1016/J. JACC.2024.05.003 · DOI
  18. Akbilgic O, Butler L, Karabayir I, et al. ECG-AI: electrocardiographic artificial intelligence model for prediction of heart failure. Eur Heart J Digit Health. 2021;2(4):626-634. https://doi.org/10. 1093/EHJDH/ZTAB080 · DOI
  19. Khan SS, Ning H, Shah SJ, et al. 10-Year risk equations for incident heart failure in the general population. J Am Coll Cardiol. 2019;73(19):2388. https://doi.org/10.1016/J.JACC.2019.02.057 · DOI
  20. Kane GC, Karon BL, Mahoney DW, et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011;306(8):856-863. https://doi.org/10.1001/ JAMA.2011.1201 · DOI
  21. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model. Circulation. 2006;113 (11):1424-1433. https://doi.org/10.1161/CIRCU- LATIONAHA.105.584102 · DOI

Cited by

Sorted by citations

Authors
Desai, A. S., Pandey, A., Suratekar, R., Ahmad, F. S., Alger, H. M., Anto, A. G., Nujum G, S., Lopez-Jimenez, F., Oh, J. K., Asfahan, S., Narasimha, S., Reddy N, S., Kaligounder, L., Ciga, M., Awasthi, S., Butler, J., Shah, S. H., & Shah, S. J.
Affiliations
  • Harvard University (US)
  • The University of Texas Southwestern Medical Center (US)
  • Northwestern University (US)
  • Mayo Clinic (US)
  • University of Mississippi (US)
Corresponding author
Desai, Akshay S.
Venue
JACC
Publisher
Elsevier BV
Published
2026-03
Volume
87
Issue
8
Pages
990-1005
ISSN
0735-1097 (ISSN-L)
OpenAlex
W4416045878
Cited by
16
References
6
Citations by year
2026: 16
FWCI
11.26
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • FNIH
  • U.S. Food and Drug Administration
  • NIH
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
heart failure prediction, 12-lead ECG, systolic dysfunction, diastolic dysfunction, risk stratification, incident heart failure, cardiovascular risk prediction, net reclassification improvement, Framingham Heart Study, Multi-Ethnic Study of Atherosclerosis, Cardiovascular Health Study
MeSH terms
Aged, Artificial Intelligence, Electrocardiography, Female, Heart Failure, Humans, Male, Middle Aged, Predictive Value of Tests, Cohort Studies, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review